mepolizumab Archives - Drugs in Context

Mepolizumab: an alternative therapy for idiopathic chronic eosinophilic pneumonia with glucocorticoid intolerance

Adam Kisling MD, Jason Jones MD, Caleb Hixson DO FCAP, David Hostler MD MPH FACP, Jordanna Hostler MD FACP

Article Type

Case Report

Published

18 Aug 2020

This article presents a case of ICEP in which mepolizumab was used as a steroid-sparing agent, resulting in improvement in markers of disease activity
and corticosteroid requirement.

Targeting eosinophils: severe asthma and beyond

Marco Caminati MD, Francesco Menzella MD, Lucia Guidolin MD, Gianenrico Senna MD

Article Type

Review

Published

23 Jul 2019

This review summarizes the rationale for the use of biologics in eosinophilic diseases and their mechanisms of action.

Effectiveness and safety of mepolizumab in severe refractory eosinophilic asthma: results in clinical practice

Olalla Montero-Pérez PharmD, María Beatriz Contreras-Rey PharmD, Ernesto Sánchez-Gómez PhD

Article Type

Original Research

Published

27 May 2019

This article analyses the effectiveness, clinical outcomes, and safety of mepolizumab in clinical practice.